Pernix Therapeutics Holdings Inc (PTX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Pernix Therapeutics Holdings Inc (PTX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010946
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that provides generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR) opioid agonist that is indicated for pain severe management, and long-term opioid treatment; a non-narcotic, non-addictive, and non-scheduled prescription sleep aid to treat insomnia; an antibiotic for infections of middle ear; and indications for depressive disorder in adults. Its branded and generic pharmaceuticals products span the therapeutic areas of neurology, psychiatry, and pain management. The company serves drug wholesalers, retail drug stores, and mass merchandisers. It has subsidiaries in the US and Ireland. Pernix Therapeutics is headquartered in Morristown, New Jersey, the US.

Pernix Therapeutics Holdings Inc (PTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Pernix Therapeutics Holdings Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Pernix Therapeutics Holdings Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Pernix Therapeutics Files a Shelf Prospectus to Raise up to USD150 Million in Public Offering of Securities 10
Pernix Therapeutics to Raise up to USD16 Million in Public Offering of Shares 11
Debt Offering 12
Pernix Therapeutics Raises USD130 Million in Private Placement of 4.25% Notes Due 2021 12
Acquisition 14
Pernix Therapeutics May Sell Itself 14
Pernix Therapeutics Holdings Inc – Key Competitors 15
Pernix Therapeutics Holdings Inc – Key Employees 16
Pernix Therapeutics Holdings Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 07, 2017: Pernix Therapeutics Reports Third Quarter 2017 Financial Results 18
Jul 27, 2017: Pernix Therapeutics Reports Second Quarter 2017 Financial Results and Provides Business Update 21
Jul 20, 2017: Pernix Therapeutics Pre-Announces Certain Preliminary Second Quarter 2017 Financial Results 24
May 15, 2017: Pernix Therapeutics Reports First Quarter 2017 Financial Results and Provides Business Update 26
Mar 28, 2017: Pernix Therapeutics Announces Fourth Quarter And Full Year 2016 Financial Results 28
Nov 10, 2016: Pernix Therapeutics Reports Third Quarter 2016 Financial Results and Provides Business Update 32
Nov 07, 2016: Pernix Therapeutics Appoints Two Board Members 36
Aug 11, 2016: Pernix Therapeutics Reports Second Quarter 2016 Financial Results and Business Update 37
May 05, 2016: Pernix Therapeutics Reports First Quarter 2016 Financial Results and Business Update 40
Mar 10, 2016: Pernix Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Business Update 42
Corporate Communications 45
Nov 16, 2017: Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors 45
Oct 17, 2017: Pernix Therapeutics Announces Planned Departure of Chief Financial Officer 46
Nov 22, 2016: Pernix appoints new board member 47
Jul 26, 2016: Pernix Therapeutics Announces Reorganization of Senior Management Team 48
Jul 07, 2016: Pernix Therapeutics Announces Restructuring of Sales Force and Operations 49
May 11, 2016: Pernix Therapeutics Announces CEO Transition 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Pernix Therapeutics Holdings Inc, Medical Equipment, Key Facts, 2016 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Pernix Therapeutics Holdings Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Pernix Therapeutics Holdings Inc, Deals By Market, 2011 to YTD 2017 8
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Pernix Therapeutics Files a Shelf Prospectus to Raise up to USD150 Million in Public Offering of Securities 10
Pernix Therapeutics to Raise up to USD16 Million in Public Offering of Shares 11
Pernix Therapeutics Raises USD130 Million in Private Placement of 4.25% Notes Due 2021 12
Pernix Therapeutics May Sell Itself 14
Pernix Therapeutics Holdings Inc, Key Competitors 15
Pernix Therapeutics Holdings Inc, Key Employees 16
Pernix Therapeutics Holdings Inc, Subsidiaries 17

★海外企業調査レポート[Pernix Therapeutics Holdings Inc (PTX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VistaGen Therapeutics Inc (VTGN):医療機器:M&Aディール及び事業提携情報
    Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate recep …
  • AirAsia Berhad:企業の戦略・SWOT・財務情報
    AirAsia Berhad - Strategy, SWOT and Corporate Finance Report Summary AirAsia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Schlumberger Ltd (SLB):企業の財務・戦略的SWOT分析
    Schlumberger Ltd (SLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Spark Capital:企業のM&A・事業提携・投資動向
    Spark Capital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Spark Capital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Gelita AG:企業の戦略・SWOT・財務情報
    Gelita AG - Strategy, SWOT and Corporate Finance Report Summary Gelita AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Superdry Plc:企業の戦略・SWOT・財務分析
    Superdry Plc - Strategy, SWOT and Corporate Finance Report Summary Superdry Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Goldin Properties Holdings Ltd:企業の戦略・SWOT・財務情報
    Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Metso Corp (METSO):電力:M&Aディール及び事業提携情報
    Summary Metso Corp (Metso) is an industrial machinery company that provides sustainable technology and services. It offers products such as mining and construction aggregates processing equipments, conveyers, separators, air classifiers, slurry pumps, industrial valves and controls, and waste shredd …
  • Suzlon Energy Limited:企業の戦略・SWOT・財務分析
    Suzlon Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Suzlon Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CACI International, Inc.:企業の戦略・SWOT・財務分析
    CACI International, Inc. - Strategy, SWOT and Corporate Finance Report Summary CACI International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • The Walt Disney Company:戦略・SWOT・企業財務分析
    The Walt Disney Company - Strategy, SWOT and Corporate Finance Report Summary The Walt Disney Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • EyeGate Pharmaceuticals Inc (EYEG):医療機器:M&Aディール及び事業提携情報
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontop …
  • Oriflame Holding AG:企業の戦略・SWOT・財務分析
    Oriflame Holding AG - Strategy, SWOT and Corporate Finance Report Summary Oriflame Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Kohinoor Energy Limited (KOHE):企業の財務・戦略的SWOT分析
    Kohinoor Energy Limited (KOHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Clean TeQ Holdings Ltd (CLQ):企業の財務・戦略的SWOT分析
    Summary Clean TeQ Holdings Ltd (Clean TeQ) is a clean technology company that offers air pollution control solutions using biotechnology-based processes. The company provides water treatment products such as advanced separations, advanced oxidation, encapsulated bacteria, continuous ionic filtration …
  • Blueberry Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a provider of nano medicines for the treatment of dermatological disorders. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea pedis; BB2312 used for the treatment of Acne diseases, …
  • Eesti Energia AS:戦略・SWOT・企業財務分析
    Eesti Energia AS - Strategy, SWOT and Corporate Finance Report Summary Eesti Energia AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Telkom SA SOC Limited:企業の戦略・SWOT・財務情報
    Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report Summary Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Selventa Inc-製薬・医療分野:企業M&A・提携分析
    Summary Selventa Inc (Selventa), formerly Genstruct Inc is a healthcare technology services provider that operates life science consulting projects. The company offers system diagnostic development services that identifies molecular mechanisms, networks and biomarkers to develop therapeutics, molecu …
  • APL Co Pte Ltd:企業の戦略的SWOT分析
    APL Co Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆